Related Experiment Video

Updated: Aug 27, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

520

A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cells

Yan Tian1,2, Mingfeng Zhang2, Mingjie Fan2

  • 1Division of Endocrinology and Metabolism, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China.

Molecular Therapy. Nucleic Acids
|September 26, 2022
PubMed

Insights

MicroRNA-26a (miR-26a) suppresses liver cancer (hepatocellular carcinoma) by inhibiting inflammation in liver and immune cells. This finding highlights miR-26a mimetics as potential treatments for liver cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Immunology

Background:

  • MicroRNAs (miRNAs) are key regulators of cellular functions.
  • miR-26a is implicated in cancer development and as a therapeutic target.
  • Mechanisms of miR-26a in suppressing liver cancer remain unclear.

Purpose of the Study:

  • To elucidate the cellular and molecular mechanisms of miR-26a in attenuating hepatocarcinogenesis.
  • To investigate the role of miR-26a in hepatocytes and myeloid cells in liver cancer suppression.

Main Methods:

  • Utilized mouse models with cell-specific overexpression of miR-26a in hepatocytes or myeloid cells.
  • Administered chemical inducers to promote hepatocellular carcinoma (HCC).
  • Analyzed the impact of miR-26a on inflammatory responses and oncogenic signaling pathways.

Main Results:

  • miR-26a overexpression significantly attenuated chemical-induced HCC in mouse models.
  • Overexpression of miR-26a broadly inhibited inflammatory responses in both hepatocytes and macrophages.
  • miR-26a decreased key oncogenic signaling pathways involved in HCC promotion.

Conclusions:

  • miR-26a plays a concerted role in both hepatocytes and Kupffer cells to suppress liver cancer.
  • miR-26a inhibits hepatocarcinogenesis by dampening inflammatory signaling.
  • miR-26a mimetics show potential for HCC prevention and treatment.

More Related Videos

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

18.8K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K